Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Industry

Fewer Pathologists and More Cancer Patients Drive Pathology Market

The global digital pathology market was worth USD 381.8 million in 2016 and is projected to grow at a CAGR of 13.2% to reach USD 708.9 million by 2021, driven by the increased adoption of digital pathology solutions worldwide due to shortage of pathologists and rise in new cancer cases. Additionally, new business models and increased FDA approvals of Whole Slide Image (WSI) scanners for primary diagnostics are expected to provide a boost to the digital pathology market. More...
02 Jan 2018

AI Outperforms Pathologists in Diagnosing Breast Cancer

A study comparing the ability of Artificial Intelligence (AI) algorithms with expert pathologists in detecting metastatic breast cancer in whole-slide images found that the machine learning outperformed the pathologists. The results of the study published in the Journal of the American Medical Association suggests that deep learning algorithms have the ability to improve diagnosis and could be used to help clinicians detect cancer in the clinic. More...
20 Dec 2017

Siemens Healthineers Acquires Fast Track Diagnostics

Siemens Healthineers has entered into an agreement to acquire Fast Track Diagnostics, which supplies diagnostics tests that can distinguish between viral, bacterial, or other infections in one test. More...
18 Dec 2017
Image: Google has announced the open source release of DeepVariant, a deep learning technology to reconstruct the true genome sequence from HTS data with significantly greater accuracy than previous classical methods (Photo courtesy of Google).

Google Releases AI Tool for Precision Medicine

Google LLC has announced the open source release of DeepVariant, a deep learning technology to reconstruct the true genome sequence from high-throughput sequencing (HTS) data with significantly greater accuracy than previous classical methods. DeepVariant, which was developed after more than two years of research by the Google Brain team, in collaboration with Verily Life Sciences, transforms the task of variant calling, as this reconstruction problem is known in genomics, into an image classification problem well-suited to Google's existing technology and expertise. Within a year of its development, the deep learning model had won the 2016 PrecisionFDA Truth Challenge award for Highest SNP Performance, outperforming state-of-the-art methods. Since then, the Google Brain team has reduced the error rate by over 50%. More...
12 Dec 2017

GE Launches Drawbridge Health to Transform Blood Collection

GE Healthcare has introduced Drawbridge Health, a privately held healthcare technology company, which is developing a people-friendly system to integrate draw, collection and stabilize blood samples into a single device. The technology which integrates engineering and proprietary chemistries is also being developed to support room temperature shipping and streamlined downstream processing, thus ensuring reliable, accurate results. More...
05 Dec 2017

Laboratory-Developed Tests Market Driven by Cancer Treatment

The global market for laboratory-developed tests (LDTs) is estimated to be worth USD 13.2 billion and will grow by nearly 10% annually, driven mainly by oncology tests which will grow 60% faster than other types of LDTs. These are the latest findings of Kalorama Information, an independent medical market research firm. More...
28 Nov 2017

Global Lab Automation Market to Reach USD 5.20 Billion by 2022

The global lab automation market is expected to grow at a CAGR of 5.1% from USD 4.06 billion in 2017 to USD 5.20 billion by 2022, driven by process miniaturization, high demand in drug discovery and clinical diagnostics, higher reproducibility and accuracy, and a large workforce demand and supply gap. Additionally, enhanced productivity and reduced costs, better personnel safety, and small volumes of samples and reagents offered by lab automation are expected to further aid the market growth. However, the high cost of lab automation is limiting its adoption among small and medium-sized labs, which is expected to restrict the market growth. More...
28 Nov 2017
New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Thyroid Test
Anti-Thyroid EIA Test


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.